Chennai, July 9 -- In one of the largest growth investments in India's IVF sector and perhaps the first, the Chennai-based Iswarya Fertility Center (IFC) on Thursday announced a growth investment of more than Rs 350 crore (about USD 37 million) from OrbiMed Asia (OrbiMed), a leading global healthcare investment firm.
The investment marks a significant milestone in IFC's mission to expand the reach of fertility care across India and help address the country's declining birth rates.
The investment will enable Iswarya to establish new centers in existing and underserved markets, strengthen clinical infrastructure, invest in digital capabilities and expand its embryology talent pipeline.
Published by HT Digital Content Services with permissi...